Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors (Q45408530)

14 December 2017

title

Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors (English)

1 reference

14 December 2017

1 reference

Amilcar Tanuri

1 reference

14 December 2017

Mariza Gonçalves Morgado

object named as

Mariza Gonçalves Morgado

1 reference

14 December 2017

author name string

José Antonio Sá-Ferreira

1 reference

14 December 2017

Patrícia Alvarez Brindeiro

1 reference

14 December 2017

Saada Chequer-Fernandez

1 reference

14 December 2017

publication date

1 January 2007

1 reference

14 December 2017

1 reference

14 December 2017

1 reference

14 December 2017

1 reference

14 December 2017

page(s)

97-102

1 reference

HIV-1 nomenclature proposal

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Identification of two HIV type 1 circulating recombinant forms in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

High frequency of recombinant genomes in HIV type 1 samples from Brazilian southeastern and southern regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naïve human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Antiretroviral-drug resistance among patients recently infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01069.X

10.1111/J.1537-2995.2007.01069.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference